Correspondence 0001193125-24-212127 from BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: Sept. 3, 2024 · CIK: 0001580063 · Accession: 0001193125-24-212127
AI Filing Summary & Sentiment
File numbers found in text: 001-39334
Letter
VIA EDGAR CORRESPONDENCE Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549-3628 Re: Preliminary Proxy Statement on Schedule 14A of Biora Therapeutics, Inc. SEC File No. 001-39334
Dear Ladies and Gentlemen:
Pursuant to Rule 14a-6(d) promulgated under the Securities Exchange Act of 1934, as amended, please be advised that Biora Therapeutics, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “Commission”) on September 3, 2024, the Company’s Preliminary Proxy Statement on Schedule 14A and proxy card in connection with the Company’s Special Meeting of Stockholders. The Company currently intends to file the Definitive Proxy Statement with the Commission on or about September 16, 2024.
If you have any questions or comments concerning the materials being transmitted herewith, please contact me at (415) 393-8297 or ABriggs@gibsondunn.com.
Sincerely,
/s/ Aaron K. Briggs
Show Raw Text
CORRESP 1 filename1.htm CORRESP Aaron K. Briggs Partner T: +1 415.393.8297 M: +1 213.393.9314 abriggs@gibsondunn.com September 3, 2024 VIA EDGAR CORRESPONDENCE Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549-3628 Re: Preliminary Proxy Statement on Schedule 14A of Biora Therapeutics, Inc. SEC File No. 001-39334 Dear Ladies and Gentlemen: Pursuant to Rule 14a-6(d) promulgated under the Securities Exchange Act of 1934, as amended, please be advised that Biora Therapeutics, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “Commission”) on September 3, 2024, the Company’s Preliminary Proxy Statement on Schedule 14A and proxy card in connection with the Company’s Special Meeting of Stockholders. The Company currently intends to file the Definitive Proxy Statement with the Commission on or about September 16, 2024. If you have any questions or comments concerning the materials being transmitted herewith, please contact me at (415) 393-8297 or ABriggs@gibsondunn.com. Sincerely, /s/ Aaron K. Briggs Aaron K. Briggs Partner Gibson, Dunn & Crutcher LLP Gibson, Dunn & Crutcher LLP One Embarcadero Center Suite 2600 | San Francisco, CA 94111-3715 | T: 415.393.8200 | F: 415.393.8306 | gibsondunn.com